Virtual diabetes group visits for managing type 2 diabetes
VIDA: Virtual Diabetes Group Visits Across Health Systems: Randomized Control Trial
This study tests whether virtual group visits can help people with type 2 diabetes manage their condition better while connecting with others for support.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Enrollment | 720 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 2 sites (Chicago, Illinois and 1 other locations) |
| Trial ID | NCT06094491 on ClinicalTrials.gov |
What this trial studies
This project evaluates the effectiveness of virtual diabetes group visits for patients with type 2 diabetes mellitus (T2DM). The approach involves providing group education and support through telehealth, allowing patients to connect with peers while receiving medical care. The study aims to implement this model across two health systems in the Chicago area, focusing on improving glycemic control and reducing healthcare utilization. Participants will engage in goal-setting and receive comprehensive care for their chronic conditions in a supportive virtual environment.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with type 2 diabetes and at least one additional cardiovascular condition.
Not a fit: Patients without type 2 diabetes or those who do not meet the specified health criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance diabetes management and improve health outcomes for patients with multiple chronic conditions.
How similar studies have performed: Other studies have shown positive outcomes with group visits and telehealth approaches, suggesting potential success for this model.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at a participating clinic (at least one visit in year prior to first GV) * Type 2 diabetes * ≥ 18 years old * A1C\>8% within 6 months prior to first GV (we will first recruit patients with A1C\>9%, then if spaces still available A1C\>8.5%, then if spaces still available A1C\>8%) * At least one additional cardiovascular condition (hypertension, heart disease, stroke, hyperlipidemia, peripheral vascular disease, or BMI ≥ 30) * English or Spanish speaking * PCP assented to recruiting patient * Patient provides written consent
Where this trial is running
Chicago, Illinois and 1 other locations
- Access Community Health Network — Chicago, Illinois, United States (Recruiting)
- Advocate Health Care — Orland Park, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Arshiya Baig, MD — University of Chicago
- Study coordinator: Melanie Norstrom
- Email: mnorstrom@medicine.bsd.uchicago.edu
- Phone: (773) 702-3962
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.